Short answer · Medically reviewed summary · Last updated: 2026-04-07
Alpha 1-antitrypsin deficiency is a genetic condition and is absolutely not contagious; it cannot be spread through touch, respiratory droplets, or any form of social contact. The condition is caused by an inherited mutation in the SERPINA1 gene, which affects the body's ability to produce a protective protein, meaning there is zero risk of transmission to family members, friends, or caregivers. What is the true cause of Alpha 1-antitrypsin deficiency? Alpha 1-antitrypsin deficiency is a hereditary disorder, meaning it is passed from parents to children through their DNA.
2 people with Alpha 1-antitrypsin deficiency have shared their first-person experience on this question at DiseaseMaps.
Alpha 1-antitrypsin deficiency is a genetic condition and is absolutely not contagious; it cannot be spread through touch, respiratory droplets, or any form of social contact. The condition is caused by an inherited mutation in the SERPINA1 gene, which affects the body's ability to produce a protective protein, meaning there is zero risk of transmission to family members, friends, or caregivers.
Alpha 1-antitrypsin deficiency is a hereditary disorder, meaning it is passed from parents to children through their DNA. The condition occurs when the liver cannot produce enough functional alpha-1 antitrypsin (AAT) protein, or when the protein produced is misfolded and gets trapped in the liver cells. This protein is essential for protecting the lungs from inflammation and damage caused by infections, pollutants, and environmental irritants. Because it is strictly a genetic, metabolic condition, it is physically impossible for a person to "catch" Alpha 1-antitrypsin deficiency from another individual.
Confusion often arises because Alpha 1-antitrypsin deficiency primarily affects the lungs, leading to symptoms like chronic obstructive pulmonary disease (COPD), chronic bronchitis, or emphysema. Because people associate chronic respiratory symptoms with infectious diseases like tuberculosis, influenza, or COVID-19, they may mistakenly assume the condition is transmissible. Furthermore, because Alpha 1-antitrypsin deficiency is rare—affecting an estimated 1 in 1,500 to 3,500 individuals of European descent—the general public lacks awareness of the disease, which can lead to unnecessary social stigma or isolation for those diagnosed.
There is absolutely no risk associated with living with, hugging, or being in close proximity to someone with Alpha 1-antitrypsin deficiency. You cannot transmit the genetic mutation through daily activities. In fact, support systems are vital for those living with the condition, as they navigate managing their respiratory and liver health. At DiseaseMaps.org, we have seen a vibrant community of 339 people with Alpha 1-antitrypsin deficiency who share their experiences, proving that social connection is a key part of the patient journey and is entirely safe for all involved.
While the disease itself is genetic, certain environmental triggers can exacerbate the symptoms of Alpha 1-antitrypsin deficiency, making the lung damage progress more rapidly. Exposure to these factors does not make the condition contagious, but it does impact the health of the patient:
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.